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Background
Placebo-controlled oral drug provocation tests (DPTs) are
an important step in drug hypersensitivity diagnosis.
Administration of placebo (an inert sostance not detect-
able from drug) is recommended to avoid psychological
influences on the interpretation of DPT results, however
actually little is known about how to deal a reaction to
placebo and how to go further with the diagnostic
procedures.
Methods
A retrospective study of patients who experienced a reac-
tion to placebo during an oral DPT between January 2009
and December 2013 was conducted at the Allergy Unit of
Molinette Hospital of Turin. Demographical characteris-
tics of patients, symptoms developed, number of further
DPTs and consequences of reactions to placebo on final
diagnosis were analyzed.
Results
55/673 patients (50 females, 5 males, mean age 44.8 years)
reacted to placebo during an oral DPT. The main reported
symptoms involved mouth and throat (itching, “lump in
the throat”, sense of constriction) in 45.4% of cases, skin
(itching, erythema, urticaria) in 27.3%, respiratory tract
(rhinitis, shortness of breath, cough, chest tightness) in
14.5%, gastrointestinal tract (nausea, heartburn) in 12.7%.
A not-specified malaise was reported by 21.8% of patients
and other symptoms (headache, agitation, paresthesias....)
by 7.3% of cases. 16/55 patients refused further tests;
39/55 patients performed further placebo-controlled oral
DPTs on different days and 16/39 reacted again to placebo
administration, developing symptoms similar to the
previous reaction. A true allergic reaction to the suspected
culprit drug was observed in 1 patient. Overall a final
diagnosis could not be reached in 27/55 patients.
Conclusions
During oral DPTs patients could develop symptoms typi-
cal of anxiety status, but also symptoms that can mimic a
true allergic reaction. A first reaction to placebo influenced
negatively the diagnostic process and the development of
further reactions to placebo. Other studies are needed to
identify therapeutic strategies for these patients and to
stop the “nocebo effect”.
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